AnalystsM. AusterM. Auster's Stock Forecasts
AnalystsM. Auster
Sectors:
Analyst Ranking
Top 25%
#1202 out of 4867 analysts
Average Return
+8.36%
Win Rate
58%11 out of 19
Risk vs Reward
Poor
Good
M. Auster's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avexis IncAVXS | +71.22% | $123.73 | $211.85 | 2018-02-28 - 2018-04-11 | Buy |
Myokardia IncMYOK | +69.97% | $42.33 | $71.95 | 2019-01-04 - 2020-01-03 | Buy |
Arena Pharmaceuticals IncARNA | +67.34% | $36.40 | $60.91 | 2018-08-07 - 2019-08-07 | Buy |
Spark Therapeutics IncONCE | +30.07% | $56.01 | $39.17 | 2018-08-07 - 2018-11-16 | Sell |
United Therapeutics CorpUTHR | +21.80% | $115.04 | $89.96 | 2018-11-01 - 2019-11-01 | Sell |
M. Auster Analyst Color
Get additional color on M. Auster's coverage of popular stocks
M. Auster's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arena Pharmaceuticals IncARNA | 3 | Buy | $77.00 | N/A | Maintains | 6 years ago |
Myokardia IncMYOK | 3 | Buy | $71.00 | N/A | Maintains | 6 years ago |
United Therapeutics CorpUTHR | 6 | Sell | $105.00 | N/A | Maintains | 6 years ago |
Spark Therapeutics IncONCE | 3 | Hold | $44.00 | N/A | Upgrades | 6 years ago |
Insmed IncINSM | 1 | Buy | $35.00 | N/A | Maintains | 7 years ago |
Anaptysbio IncANAB | 1 | Buy | $147.00 | N/A | Maintains | 7 years ago |
Ptc Therapeutics IncPTCT | 1 | Buy | $53.00 | N/A | Maintains | 7 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $122.00 | N/A | Maintains | 7 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $60.00 | N/A | Maintains | 7 years ago |
Esperion Therapeutics IncESPR | 1 | Buy | $73.00 | N/A | Maintains | 7 years ago |
Avexis IncAVXS | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.